Anti-IGF-I receptor antibody

Details for Australian Patent Application No. 2003241580 (hide)

Owner ImmunoGen, Inc

Inventors Tavares, Daniel J.; Dagdigian, Nancy E.; Singh, Rajeeva

Agent Griffith Hack

Pub. Number AU-B-2003241580

PCT Number PCT/US03/16211

PCT Pub. Number WO2003/106621

Priority 10/170,390 14.06.02 US

Filing date 12 June 2003

Wipo publication date 31 December 2003

Acceptance publication date 19 November 2009

International Classifications

G01N 33/534 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with radioactive label

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 5/16 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 10/170,390 14.06.02 US

26 February 2004 Application Open to Public Inspection

  Published as AU-B-2003241580

26 June 2008 Alteration of Name

  The name of the applicant has been altered to ImmunoGen, Inc.

19 November 2009 Application Accepted

  Published as AU-B-2003241580

4 March 2010 Opposition Lodged

  Amgen Inc. has lodged an opposition against ImmunoGen, Inc.

29 March 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 25 Jan 2012. Address for service in Australia - Griffith Hack Level 10 167 Eagle Street Brisbane QLD 4001 2004

19 July 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 25 Jan and 15 Feb 2012 2004

23 August 2012 Opposition Withdrawn

  The opposition by Amgen Inc. against ImmunoGen, Inc has been withdrawn.

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003241581-MICROWAVE ELECTRODELESS LAMP

2003241579-Amide linker peroxisome proliferator activated receptor modulators